| Title |
Hypertension in pediatric patients with chronic kidney disease: management challenges
|
|---|---|
| Published in |
International Journal of Nephrology and Renovascular Disease, July 2017
|
| DOI | 10.2147/ijnrd.s100891 |
| Pubmed ID | |
| Authors |
Claire M Gallibois, Natasha A Jawa, Damien G Noone |
| Abstract |
In contrast to adults where hypertension is a leading cause of chronic kidney disease, in pediatrics, hypertension is predominantly a sequela, however, an important one that, like in adults, is likely associated with a more rapid decline in kidney function or progression of chronic kidney disease to end stage. There is a significant issue with unrecognized, or masked, hypertension in childhood chronic kidney disease. Recent evidence and, therefore, guidelines now suggest targeting a blood pressure of <50th percentile for age, sex, and height in children with proteinuria and chronic kidney disease. This often cannot be achieved by monotherapy and additional agents need to be added. Blockade of the renin angiotensin aldosterone system represents the mainstay of therapy, although often limited by the side effect of hyperkalemia. The addition of a diuretic, at least in the earlier stages of chronic kidney disease, might help mitigate this problem. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 17% |
| Peru | 1 | 17% |
| United States | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 118 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 18 | 15% |
| Student > Master | 17 | 14% |
| Student > Postgraduate | 9 | 8% |
| Other | 6 | 5% |
| Student > Doctoral Student | 5 | 4% |
| Other | 14 | 12% |
| Unknown | 49 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 30% |
| Nursing and Health Professions | 15 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Arts and Humanities | 2 | 2% |
| Other | 6 | 5% |
| Unknown | 52 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2022.
All research outputs
#2,397,110
of 22,994,508 outputs
Outputs from International Journal of Nephrology and Renovascular Disease
#17
of 239 outputs
Outputs of similar age
#47,634
of 314,052 outputs
Outputs of similar age from International Journal of Nephrology and Renovascular Disease
#2
of 9 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 239 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,052 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.